![]() |
|
|

Department of Biochemistry and
*
Department of Physiology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, The Peoples Republic of China and
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, The Peoples Republic of China
2To whom correspondence should be addressed. E-mail: zhenyuchen{at}cuhk.edu.hk.
| ABSTRACT |
|---|
|
|
|---|
TF2B
TF2A
> TF1
EC > EGC. Four TF derivatives
also demonstrated a dose-dependent antioxidant activity in
Cu+2-mediated LDL oxidation at concentrations of 540
µmol/L. These results demonstrate that the TF present
in black tea possess at least the same antioxidant potency as catechins
present in green tea, and that the conversion of catechins to TF during
fermentation in making black tea does not alter significantly their
free radicalscavenging activity.
KEY WORDS: black tea catechins green tea low density lipoprotein oxidation theaflavins.
| INTRODUCTION |
|---|
|
|
|---|
2 g/100 g of the dried water extract of
black tea. The major TF in black and oolong tea are theaflavin
(TF1), theaflavin-3-gallate
(TF2A), theaflavin-3'-gallate
(TF2B) and theaflavin-3,3'-digallate
(TF3) (Fig. 1
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Total catechins from Chinese longjing green tea (Huangshan Forestry
Farm, Xiaoshan, Zhejiang, China) were extracted and isolated as
previously described (17)
. To purify TF, qimen black tea
(2.25 kg) was purchased locally and was first extracted three times
using 13.5 L of 70% ethanol. After the removal of ethanol in a rotary
evaporator, the remaining water solution was extracted subsequently
using chloroform (3 L), ethyl acetate (2 L) and butanol (2 L). The
ethyl acetate extract was then applied onto a silica gel column (80
x 6.5 cm i.d.; silica gel 60M, 230240 mesh). The total TF
fraction was obtained when the column was eluted with a mixture of
chloroform and ethyl acetate (1:1, v/v) followed by increasing the
ratio of chloroform to ethyl acetate to 4:1 (v/v). The total TF
fraction was then subjected to a Sephadex LH-20 column (50 x6.0 cm
i.d.) and eluted with 15 L of 70% ethanol to obtain crude
TF1, TF2A, TF2B and TF3
fractions. TF1 was purified on a Sephadex LH-20 column B
(50 x 2.5 cm i.d.) and eluted using 4 L of 30% acetone in water
containing 2% acetic acid. TF2A, TF2B and TF3
were similarly isolated and purified. The chemical structures of the
four purified TF were verified using the melting point test, TLC, UV
spectrometry, liquid chromatography-mass spectrometry and
1H nuclear magnetic resonance spectrometry. The results
were in agreement with those previously reported (19)
.
LDL isolation.
Fresh blood was collected and pooled from healthy subjects
(n = 20) at the Prince of Wales Hospital, The
Chinese University of Hong Kong, Shatin, Hong Kong. To prevent the
lipoprotein from oxidative modification, EDTA (2.7 mmol/L) and
NaN3 (7.7 mmol/L) solutions were immediately added before
LDL were isolated from serum according to the method previously
described (17)
. The protein content of isolated LDL was
determined using the method of Lowry et al. (20)
. The
protocol was approved by the Committee of Human Ethics, The Chinese
University of Hong Kong.
LDL oxidation.
Oxidation of LDL was conducted as previously described by Puhl et al.
(21)
. In brief, the stock LDL fraction (5 g protein/L) was
dialyzed against 100 volumes of the degassed dialysis solution (pH
= 7.4) containing 0.01 mol/L sodium phosphate, 9 g/L NaCI, 10
µmol/L EDTA and 7.7 mmol/L NaN3 in the
dark for 24 h. The dialysis solution was changed at least four
times. Then, the dialyzed LDL were diluted to 250 mg protein/L with
0.01 mol/L sodium phosphate buffer (pH = 7.4). For the control
incubation tubes, 0.4 mL LDL (250 mg/L) was mixed with 50
µL of 50 µmol/L CuSO4
solution and 50 µL of 0.01 mol/L sodium phosphate
buffer (pH = 7.4), and incubated at 37°C for up to 24 h.
For the experimental tubes, 0.4 mL LDL (250 mg protein/L) was
preincubated with 50 µL of varying concentrations of
individual catechins and TF for 5 min. Then, 50 µL of
50 µmol/L CuSO4 solution was added to
initiate the oxidation, followed by incubation at 37°C for up to
24 h. The oxidation was then stopped by the addition of 25
µL of 27 mmol/L EDTA and cooled to 4°C. The degree
of LDL oxidation was monitored by measuring the production of
thiobarbituric acidreactive substances (TBARS) as previously
described (17)
. The LDL-incubated tubes were
immediately combined with 2 mL of 0.67% thiobarbituric acid
and 15% trichloroacetic acid in 0.1 mol/L HCl solution. The incubation
mixture was then heated at 95°C for 1 h, cooled on ice and
centrifuged at 1000 x g for 20 min. TBARS were
then determined by measuring the absorbance at 532 nm. The calibration
was done using a malondialdehyde (MDA) standard solution prepared from
tetramethoxylpropane. The value of TBARS was expressed as nmol MDA/mg
LDL protein.
Conjugated dienes.
Oxidation of LDL was also monitored by measuring the production of
conjugated dienes. In brief, the same amount of human LDL was incubated
at 37°C and the oxidation was initiated by the same concentration of
Cu+2 as described above. The absorbance of conjugated
dienes at 234 nm was recorded at 0, 4, 8, 12, 16, 20 and 24 h. The
change in the absorbance (
234 nm) was used as an index of LDL
oxidation.
Statistics.
Data were expressed as means ± SD, n = 67. For the dose effect of individual TF on Cu+2-mediated LDL oxidation, the linear regression was conducted between the induction time and the dose of each TF. The trends were considered significant when P < 0.01. For the TBARS assay, differences were analyzed by a three-factor ANOVA with concentrations, types of catechins and TF, and the time of incubation as factors. Sigmastat (Jandel Scientific Software, San Rafael, CA) was used for all analyses. The differences were considered significant when P < 0.01.
| RESULTS |
|---|
|
|
|---|
TBARS were used as an index of LDL oxidation. When all catechins and TF
were compared at 5 µmol/L, the antioxidant activity was in
the order: TF3 > ECG > EGCG
TF2B
TF2A > TF1
EC > EGC (Fig. 2
). A similar order was seen when oxidation was measured by conjugated
diene production (data not shown) Under the same experimental
conditions, vitamin C (ascorbic acid) had little or no protective
activity for human LDL.
|
|
| DISCUSSION |
|---|
|
|
|---|
EGCG
TF2B
TF2A > TF1
EC > EGC in decreasing order using
human LDL as the oxidation model. Together with the study by Yoshino et
al. (22)
TF are the products formed when catechins are oxidized and dimerized.
TF1 was formed by the oxidation and dimerization
of EC and EGC (23)
. As shown in Figure 2
, the antioxidant
activity of TF1 was similar to that of EC (lag
time = 4 h) but it was stronger than that of EGC
(P < 0.01). Similarly, TF2A had
an antioxidant activity similar to that of EGCG but it was more
effective than EC; the former was produced when the latter two
underwent oxidation and dimerization (23)
. Compared with
the two precursors, TF2B was weaker than ECG but
stronger than EGC in protecting LDL from oxidation (Fig. 2)
.
Interestingly, TF3 was more effective than its
two precursors, ECG and EGCG, in preventing LDL from oxidation (Fig. 2)
. The present comparisons indicate that TF are at least as effective
as their precursors in protecting human LDL from oxidation. The
conversion of catechins to theaflavins during the manufacture of black
tea does not affect their free radicalscavenging potency on the same
molar basis.
It is interesting that TF3 containing two gallate
groups inhibited LDL oxidation more than TF2A and
TF2B, which have only one gallate group.
Similarly, TF2A and TF2B
had stronger antioxidant activities than TF1
because the former two have one gallate group, whereas the latter
contain no gallate group. This observation is consistent with that of
Shiraki et al. (24)
, who showed that the galloyl moiety of
TF was essential for their potent antioxidant activities. Similarly, EC
and EGC were less active than their corresponding gallate derivatives,
ECG and EGCG, as antioxidants against LDL oxidation (17)
.
Perhaps an additional group increases the total number of phenyl
hydroxyl groups and makes the gallate-containing catechins and TF
more able to donate a proton due to the resonance delocalization.
The present study in vitro, although not directly applicable to humans,
may have some implications for individuals who often consume black or
green tea. It was previously demonstrated that the ingestion of green
and black teas significantly increased human plasma antioxidant
capacity in vivo (25)
. This was also in agreement with the
observation that total plasma lipid peroxides and oxidation of LDL were
significantly reduced in hamsters fed a high cholesterol diet and given
green and black tea (26)
. All data presented here suggest
that drinking black tea has benefits equal to those of drinking green
tea in terms of their antioxidant capacity.
| FOOTNOTES |
|---|
3 Abbreviations used: EC, (-)-epicatechin; ECG,
(-)-epicatechin gallate; EGC, (-)-epigallocatechin; EGCG,
(-)-epigallocatechin gallate; MDA, malondialdehyde; ox-LDL,
oxidatively modified LDL; TBARS, thiobarbituric acidreactive
substances; TF1, theaflavin; TF2A,
theaflavin-3-gallate; TF2B, theaflavin-3'-gallate;
TF3, theaflavin-3,3'-digallate. ![]()
Manuscript received March 2, 2001. Revision accepted May 31, 2001.
| LITERATURE CITED |
|---|
|
|
|---|
1. Zhu Q. Y. & Chen Z. Y. (1999) Isolation and analysis of green tea polyphenols by HPLC. Anal. Lab. 18:70-72.
2. Subramanian N., Venkatesh P., Ganguli S. & Sinkar V. P. (1999) Role of polyphenol oxidase and peroxidase in the generation of black tea theaflavins. J. Agric. Food Chem. 47:2571-2578.[Medline]
3. Imai K. & Nakachi K. (1985) Cross sectional study of effects of drinking green tea on cardiovascular and liver disease. Biochem. Med. J. 310:693-696.
4. Buschman J. L. (1998) Green tea and cancer in humans: a review of the literature. Nutr. Cancer 31:51-57.
5. Yang C. S. (1999) Tea and health. Nutrition 15:946-949.[Medline]
6.
Henry J. P. & Stephens-Larson P. (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6:437-444.
7. Hara Y., Matsuzaki T. & Suzuki T. (1987) Angiotensin I converting enzyme inhibiting activity of tea components. J. Agric. Chem. Soc. Jpn. 61:803-808.
8. Zhang A., Zhu Q. Y., Luk Y. S., Ho K. Y., Fung K. P. & Chen Z. Y. (1997b) Inhibitory effects of jasmine green tea epicatechin isomers on free radical-induced lysis of red blood cells. Life Sci 61:383-394.[Medline]
9. Halder J. & Bhaduri A. N. (1998) Protective role of black tea against oxidative damage of human red blood cells. Biochem. Biophys. Res. Commun. 244:903-907.[Medline]
10.
Chan P. T., Fong W. P., Cheung Y. L., Huang Y., Ho W.K.K. & Chen Z. Y. (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters fed a high-fat diet. J. Nutr. 129:1094-1101.
11. Kono S., Shinchi K., Ikeda N., Yanai F. & Imanishi K. (1992) Green tea consumption and serum lipid profile: a cross-sectional study in Northern Kyush. Jpn. Prev. Med. 21:526-531.
12.
Palinski W., Rosenfeld M. E., Yla-Herttuala S., Gurter G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Sterberg D. & Witztum J. L. (1989) Low-density lipoprotein undergoes oxidative modification in vitro. Proc. Natl. Acad. Sci. U.S.A. 86:1372-1376.
13. Jialal I. & Devaraj S. (1996) Low-density lipoprotein oxidation, antioxidants, and atheroscelerosis: a clinical biochemistry perspective. Clin. Chem. 4:498-506.
14. Haberland M. E., Fong D. & Cheung L. (1988) Malodialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits 1988 Science (Washington DC) 241 215218. .
15. Shaikh M., Martini S., Quiney J. R., Baskerville P., La Ville A. E., Brows N. L., Duffield R., Turner P. R. & Lewis B. (1988) Modified plasma-derived lipoproteins in human atherosclerosis plaques. Atherosclerosis 69:165-172.[Medline]
16. Steinberg D., Parthasarathy S., Carew T. W., Knoo J. C. & Witztum J. L. (1989) Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.[Medline]
17. Zhang A., Chan P. T., Luk Y. S., Ho W.K.K. & Chen Z. Y. (1997) Inhibitory effect of jasmine green tea epicatechin isomers on LDL-oxidation. J. Nutr. Biochem. 8:334-340.
18. Zhu Q. Y., Huang Y., Tsang D. & Chen Z. Y. (1999) Regeneration of alpha-tocopherol in human low-density lipoproteins by green tea catechin. J. Agric. Food Chem. 47:2020-2025.[Medline]
19. Nonaka G. I., Hashimoto F. & Nishoka I. (1986) Tannins and related compounds 1986 XXXVI. Isolation and structures of theaflagallins new red pigments from black tea. Chem. Pharm. Bull. 34 6165. .
20.
Lowry O. H., Rosebrough N. J., Farr A. L. & Randall R. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. Pahl H., Wang G. & Esterbauer H. (1994) Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 233:425-434.[Medline]
22. Yoshino K., Hara Y., Sano M. & Tomita S. (1994) Antioxidative effects of black tea theaflavins and thearubigin on lipid perioxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol. Pharm. Bull. 17:146-149.[Medline]
23. Sanderson G. W. (1972) The chemistry of tea and tea manufacturing. Reneckles V. C. Tso T. C. eds. Structural and Functional Aspects of Phytochemistry: Recent Advance in Phytochemistry 5:247-317 Academic Press New York, NY. .
24. Shiraki M., Hara Y., Osawa T., Kumon H., Nakayama T. & Kawakishi S. (1994) Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat. Res. 323:29-34.[Medline]
25. Sarafini M., Ghiaelli A. & Ferro-Luzzi A. (1996) In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr. 50:28-32.[Medline]
26. Vinson J. A. & Dabbagh Y. A. (1998) Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in hamsters: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett 433:44-46.[Medline]
This article has been cited by other articles:
![]() |
N. Kumar, L. Titus-Ernstoff, P. A. Newcomb, A. Trentham-Dietz, G. Anic, and K. M. Egan Tea Consumption and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 341 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Call, K. A. Voelker, A. V. Wolff, R. P. McMillan, N. P. Evans, M. W. Hulver, R. J. Talmadge, and R. W. Grange Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract J Appl Physiol, September 1, 2008; 105(3): 923 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-P. Ng, L. Feng, M. Niti, E.-H. Kua, and K.-B. Yap Tea consumption and cognitive impairment and decline in older Chinese adults Am. J. Clinical Nutrition, July 1, 2008; 88(1): 224 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murase, S. Haramizu, N. Ota, and T. Hase Tea catechin ingestion combined with habitual exercise suppresses the aging-associated decline in physical performance in senescence-accelerated mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R281 - R289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo Coffee and Tea Consumption and Risk of Stroke Subtypes in Male Smokers Stroke, June 1, 2008; 39(6): 1681 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, H. Dreger, K. Stangl, and M. Lorenz Molecular targets of tea polyphenols in the cardiovascular system Cardiovasc Res, January 15, 2007; 73(2): 348 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhong, J. K Furne, and M. D Levitt An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 551 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Siddiqui, N. Zaman, M. H. Aziz, S. R. Reagan-Shaw, S. Sarfaraz, V. M. Adhami, N. Ahmad, S. Raisuddin, and H. Mukhtar Inhibition of CWR22R{nu}1 tumor growth and PSA secretion in athymic nude mice by green and black teas Carcinogenesis, April 1, 2006; 27(4): 833 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-N. Chen, C. P. C. Lin, K.-K. Huang, W.-C. Chen, H.-P. Hsieh, P.-H. Liang, and J. T.-A. Hsu Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3) Evid. Based Complement. Altern. Med., June 1, 2005; 2(2): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Chen, G. L Tipoe, E. C Liong, H. S. So, K.-M. Leung, W.-M. Tom, P. C. Fung, and A. A Nanji Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants Am. J. Clinical Nutrition, September 1, 2004; 80(3): 742 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D Sesso, R. S Paffenbarger Jr, Y. Oguma, and I-M. Lee Lack of association between tea and cardiovascular disease in college alumni Int. J. Epidemiol., August 1, 2003; 32(4): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Misra, R. Chattopadhyay, S. Banerjee, D. J. Chattopadhyay, and I. B. Chatterjee Black Tea Prevents Cigarette Smoke-Induced Oxidative Damage of Proteins in Guinea Pigs J. Nutr., August 1, 2003; 133(8): 2622 - 2628. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Lee, H. J. Lee, and C. Y. Lee Antioxidant Activity of Black Tea vs. Green Tea J. Nutr., April 1, 2002; 132(4): 785 - 785. [Full Text] [PDF] |
||||
![]() |
Z. Y. Chen, L. K. Leung, and Y. Huang Reply to K.W. Lee, H.J. Lee and C.Y. Lee J. Nutr., April 1, 2002; 132(4): 786 - 786. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||